nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—ALB—hematologic cancer	0.154	1	CbGaD
Oxcarbazepine—CYP3A5—Daunorubicin—hematologic cancer	0.0245	0.047	CbGbCtD
Oxcarbazepine—ALB—Imatinib—hematologic cancer	0.0233	0.0448	CbGbCtD
Oxcarbazepine—CYP3A5—Thalidomide—hematologic cancer	0.0223	0.0428	CbGbCtD
Oxcarbazepine—CYP3A5—Teniposide—hematologic cancer	0.0213	0.0408	CbGbCtD
Oxcarbazepine—CYP2C19—Bortezomib—hematologic cancer	0.0206	0.0396	CbGbCtD
Oxcarbazepine—CYP3A5—Ifosfamide—hematologic cancer	0.0196	0.0377	CbGbCtD
Oxcarbazepine—CYP3A5—Imatinib—hematologic cancer	0.0187	0.036	CbGbCtD
Oxcarbazepine—CYP2C19—Thalidomide—hematologic cancer	0.018	0.0345	CbGbCtD
Oxcarbazepine—CYP2C19—Teniposide—hematologic cancer	0.0171	0.0329	CbGbCtD
Oxcarbazepine—CYP3A4—Bexarotene—hematologic cancer	0.0163	0.0313	CbGbCtD
Oxcarbazepine—CYP2C19—Ifosfamide—hematologic cancer	0.0158	0.0304	CbGbCtD
Oxcarbazepine—ALB—Prednisone—hematologic cancer	0.0154	0.0295	CbGbCtD
Oxcarbazepine—CYP3A4—Busulfan—hematologic cancer	0.0151	0.0291	CbGbCtD
Oxcarbazepine—CYP3A4—Lomustine—hematologic cancer	0.0151	0.0291	CbGbCtD
Oxcarbazepine—CYP2C19—Imatinib—hematologic cancer	0.0151	0.029	CbGbCtD
Oxcarbazepine—CYP3A5—Dasatinib—hematologic cancer	0.015	0.0289	CbGbCtD
Oxcarbazepine—ALB—Irinotecan—hematologic cancer	0.0146	0.028	CbGbCtD
Oxcarbazepine—CYP3A4—Thiotepa—hematologic cancer	0.0135	0.0259	CbGbCtD
Oxcarbazepine—CYP3A5—Irinotecan—hematologic cancer	0.0117	0.0225	CbGbCtD
Oxcarbazepine—CYP3A4—Methoxsalen—hematologic cancer	0.0105	0.0201	CbGbCtD
Oxcarbazepine—CYP3A5—Vincristine—hematologic cancer	0.0102	0.0197	CbGbCtD
Oxcarbazepine—CYP3A4—Bortezomib—hematologic cancer	0.00997	0.0192	CbGbCtD
Oxcarbazepine—CYP2C19—Prednisone—hematologic cancer	0.00996	0.0191	CbGbCtD
Oxcarbazepine—CYP3A4—Daunorubicin—hematologic cancer	0.00954	0.0183	CbGbCtD
Oxcarbazepine—CYP3A5—Etoposide—hematologic cancer	0.00937	0.018	CbGbCtD
Oxcarbazepine—CYP3A4—Cytarabine—hematologic cancer	0.00841	0.0162	CbGbCtD
Oxcarbazepine—CYP3A4—Teniposide—hematologic cancer	0.00829	0.0159	CbGbCtD
Oxcarbazepine—CYP3A5—Dexamethasone—hematologic cancer	0.00771	0.0148	CbGbCtD
Oxcarbazepine—ALB—Methotrexate—hematologic cancer	0.00771	0.0148	CbGbCtD
Oxcarbazepine—CYP3A4—Ifosfamide—hematologic cancer	0.00765	0.0147	CbGbCtD
Oxcarbazepine—CYP3A4—Imatinib—hematologic cancer	0.00731	0.014	CbGbCtD
Oxcarbazepine—CYP3A4—Ruxolitinib—hematologic cancer	0.00688	0.0132	CbGbCtD
Oxcarbazepine—CYP3A4—Nilotinib—hematologic cancer	0.00664	0.0128	CbGbCtD
Oxcarbazepine—CYP3A4—Vinorelbine—hematologic cancer	0.00658	0.0126	CbGbCtD
Oxcarbazepine—CYP2C19—Dexamethasone—hematologic cancer	0.00622	0.0119	CbGbCtD
Oxcarbazepine—CYP3A4—Triamcinolone—hematologic cancer	0.00602	0.0116	CbGbCtD
Oxcarbazepine—CYP3A4—Dasatinib—hematologic cancer	0.00587	0.0113	CbGbCtD
Oxcarbazepine—CYP3A4—Mitoxantrone—hematologic cancer	0.0058	0.0111	CbGbCtD
Oxcarbazepine—CYP3A4—Betamethasone—hematologic cancer	0.00517	0.00993	CbGbCtD
Oxcarbazepine—CYP3A4—Prednisolone—hematologic cancer	0.0051	0.00979	CbGbCtD
Oxcarbazepine—CYP3A4—Prednisone—hematologic cancer	0.00481	0.00925	CbGbCtD
Oxcarbazepine—CYP3A4—Irinotecan—hematologic cancer	0.00456	0.00877	CbGbCtD
Oxcarbazepine—CYP3A4—Vinblastine—hematologic cancer	0.00406	0.00779	CbGbCtD
Oxcarbazepine—CYP3A4—Vincristine—hematologic cancer	0.00399	0.00766	CbGbCtD
Oxcarbazepine—CYP3A4—Etoposide—hematologic cancer	0.00366	0.00702	CbGbCtD
Oxcarbazepine—CYP3A4—Dexamethasone—hematologic cancer	0.00301	0.00577	CbGbCtD
Oxcarbazepine—CYP3A4—Doxorubicin—hematologic cancer	0.00249	0.00479	CbGbCtD
Oxcarbazepine—Indapamide—CA9—hematologic cancer	0.000462	0.291	CrCbGaD
Oxcarbazepine—Magnesium salicylate—ALB—hematologic cancer	0.000138	0.0868	CrCbGaD
Oxcarbazepine—Piroxicam—ALB—hematologic cancer	0.000132	0.0832	CrCbGaD
Oxcarbazepine—Desipramine—SLC22A1—hematologic cancer	0.000123	0.0776	CrCbGaD
Oxcarbazepine—Imipramine—SLC22A1—hematologic cancer	0.000104	0.0658	CrCbGaD
Oxcarbazepine—Epinastine—ABCB1—hematologic cancer	8.4e-05	0.053	CrCbGaD
Oxcarbazepine—Warfarin—ALB—hematologic cancer	7.39e-05	0.0466	CrCbGaD
Oxcarbazepine—Clobazam—ABCB1—hematologic cancer	5.62e-05	0.0355	CrCbGaD
Oxcarbazepine—Carbamazepine—ABCB1—hematologic cancer	5.27e-05	0.0333	CrCbGaD
Oxcarbazepine—Nortriptyline—ALB—hematologic cancer	4.55e-05	0.0287	CrCbGaD
Oxcarbazepine—Trimipramine—ABCB1—hematologic cancer	4.09e-05	0.0258	CrCbGaD
Oxcarbazepine—Promethazine—ABCB1—hematologic cancer	3.94e-05	0.0248	CrCbGaD
Oxcarbazepine—Doxepin—ABCB1—hematologic cancer	3.9e-05	0.0246	CrCbGaD
Oxcarbazepine—Desipramine—ABCB1—hematologic cancer	3.58e-05	0.0226	CrCbGaD
Oxcarbazepine—Diazepam—ALB—hematologic cancer	3.44e-05	0.0217	CrCbGaD
Oxcarbazepine—Diazepam—ABCB1—hematologic cancer	3.28e-05	0.0207	CrCbGaD
Oxcarbazepine—Amitriptyline—ALB—hematologic cancer	3.16e-05	0.0199	CrCbGaD
Oxcarbazepine—Imipramine—ABCB1—hematologic cancer	3.03e-05	0.0191	CrCbGaD
Oxcarbazepine—Amitriptyline—ABCB1—hematologic cancer	3.01e-05	0.019	CrCbGaD
Oxcarbazepine—Rash—Cisplatin—hematologic cancer	1.84e-05	6.4e-05	CcSEcCtD
Oxcarbazepine—Dermatitis—Cisplatin—hematologic cancer	1.83e-05	6.39e-05	CcSEcCtD
Oxcarbazepine—Malnutrition—Epirubicin—hematologic cancer	1.83e-05	6.38e-05	CcSEcCtD
Oxcarbazepine—Diarrhoea—Etoposide—hematologic cancer	1.82e-05	6.36e-05	CcSEcCtD
Oxcarbazepine—Anorexia—Prednisone—hematologic cancer	1.82e-05	6.35e-05	CcSEcCtD
Oxcarbazepine—Eye disorder—Doxorubicin—hematologic cancer	1.82e-05	6.34e-05	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Methotrexate—hematologic cancer	1.82e-05	6.33e-05	CcSEcCtD
Oxcarbazepine—Tinnitus—Doxorubicin—hematologic cancer	1.82e-05	6.33e-05	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Dexamethasone—hematologic cancer	1.81e-05	6.3e-05	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Betamethasone—hematologic cancer	1.81e-05	6.3e-05	CcSEcCtD
Oxcarbazepine—Flushing—Doxorubicin—hematologic cancer	1.81e-05	6.3e-05	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Doxorubicin—hematologic cancer	1.81e-05	6.3e-05	CcSEcCtD
Oxcarbazepine—Flatulence—Epirubicin—hematologic cancer	1.81e-05	6.29e-05	CcSEcCtD
Oxcarbazepine—Tension—Epirubicin—hematologic cancer	1.8e-05	6.26e-05	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Betamethasone—hematologic cancer	1.79e-05	6.26e-05	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.79e-05	6.26e-05	CcSEcCtD
Oxcarbazepine—Dysgeusia—Epirubicin—hematologic cancer	1.79e-05	6.25e-05	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Triamcinolone—hematologic cancer	1.78e-05	6.21e-05	CcSEcCtD
Oxcarbazepine—Nervousness—Epirubicin—hematologic cancer	1.78e-05	6.2e-05	CcSEcCtD
Oxcarbazepine—Back pain—Epirubicin—hematologic cancer	1.77e-05	6.18e-05	CcSEcCtD
Oxcarbazepine—Angiopathy—Doxorubicin—hematologic cancer	1.77e-05	6.16e-05	CcSEcCtD
Oxcarbazepine—Malaise—Methotrexate—hematologic cancer	1.77e-05	6.15e-05	CcSEcCtD
Oxcarbazepine—Dizziness—Etoposide—hematologic cancer	1.76e-05	6.15e-05	CcSEcCtD
Oxcarbazepine—Immune system disorder—Doxorubicin—hematologic cancer	1.76e-05	6.13e-05	CcSEcCtD
Oxcarbazepine—Vertigo—Methotrexate—hematologic cancer	1.76e-05	6.13e-05	CcSEcCtD
Oxcarbazepine—Leukopenia—Methotrexate—hematologic cancer	1.75e-05	6.11e-05	CcSEcCtD
Oxcarbazepine—Chills—Doxorubicin—hematologic cancer	1.75e-05	6.09e-05	CcSEcCtD
Oxcarbazepine—Urticaria—Dexamethasone—hematologic cancer	1.74e-05	6.08e-05	CcSEcCtD
Oxcarbazepine—Urticaria—Betamethasone—hematologic cancer	1.74e-05	6.08e-05	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.74e-05	6.07e-05	CcSEcCtD
Oxcarbazepine—Dizziness—Prednisolone—hematologic cancer	1.74e-05	6.06e-05	CcSEcCtD
Oxcarbazepine—Arrhythmia—Doxorubicin—hematologic cancer	1.74e-05	6.06e-05	CcSEcCtD
Oxcarbazepine—Asthenia—Triamcinolone—hematologic cancer	1.74e-05	6.05e-05	CcSEcCtD
Oxcarbazepine—Body temperature increased—Betamethasone—hematologic cancer	1.74e-05	6.05e-05	CcSEcCtD
Oxcarbazepine—Body temperature increased—Dexamethasone—hematologic cancer	1.74e-05	6.05e-05	CcSEcCtD
Oxcarbazepine—Abdominal pain—Betamethasone—hematologic cancer	1.74e-05	6.05e-05	CcSEcCtD
Oxcarbazepine—Abdominal pain—Dexamethasone—hematologic cancer	1.74e-05	6.05e-05	CcSEcCtD
Oxcarbazepine—Nausea—Cisplatin—hematologic cancer	1.73e-05	6.03e-05	CcSEcCtD
Oxcarbazepine—Insomnia—Prednisone—hematologic cancer	1.73e-05	6.03e-05	CcSEcCtD
Oxcarbazepine—Vision blurred—Epirubicin—hematologic cancer	1.73e-05	6.02e-05	CcSEcCtD
Oxcarbazepine—Alopecia—Doxorubicin—hematologic cancer	1.72e-05	6e-05	CcSEcCtD
Oxcarbazepine—Pruritus—Triamcinolone—hematologic cancer	1.71e-05	5.96e-05	CcSEcCtD
Oxcarbazepine—Cough—Methotrexate—hematologic cancer	1.71e-05	5.95e-05	CcSEcCtD
Oxcarbazepine—Mental disorder—Doxorubicin—hematologic cancer	1.71e-05	5.95e-05	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Epirubicin—hematologic cancer	1.7e-05	5.92e-05	CcSEcCtD
Oxcarbazepine—Convulsion—Methotrexate—hematologic cancer	1.7e-05	5.91e-05	CcSEcCtD
Oxcarbazepine—Vomiting—Etoposide—hematologic cancer	1.7e-05	5.91e-05	CcSEcCtD
Oxcarbazepine—Malnutrition—Doxorubicin—hematologic cancer	1.69e-05	5.91e-05	CcSEcCtD
Oxcarbazepine—Agitation—Epirubicin—hematologic cancer	1.68e-05	5.87e-05	CcSEcCtD
Oxcarbazepine—Dyspepsia—Prednisone—hematologic cancer	1.68e-05	5.86e-05	CcSEcCtD
Oxcarbazepine—Rash—Etoposide—hematologic cancer	1.68e-05	5.86e-05	CcSEcCtD
Oxcarbazepine—Dermatitis—Etoposide—hematologic cancer	1.68e-05	5.86e-05	CcSEcCtD
Oxcarbazepine—Headache—Etoposide—hematologic cancer	1.67e-05	5.82e-05	CcSEcCtD
Oxcarbazepine—Flatulence—Doxorubicin—hematologic cancer	1.67e-05	5.82e-05	CcSEcCtD
Oxcarbazepine—Chest pain—Methotrexate—hematologic cancer	1.67e-05	5.81e-05	CcSEcCtD
Oxcarbazepine—Myalgia—Methotrexate—hematologic cancer	1.67e-05	5.81e-05	CcSEcCtD
Oxcarbazepine—Arthralgia—Methotrexate—hematologic cancer	1.67e-05	5.81e-05	CcSEcCtD
Oxcarbazepine—Tension—Doxorubicin—hematologic cancer	1.66e-05	5.8e-05	CcSEcCtD
Oxcarbazepine—Decreased appetite—Prednisone—hematologic cancer	1.66e-05	5.79e-05	CcSEcCtD
Oxcarbazepine—Dysgeusia—Doxorubicin—hematologic cancer	1.66e-05	5.78e-05	CcSEcCtD
Oxcarbazepine—Rash—Prednisolone—hematologic cancer	1.66e-05	5.78e-05	CcSEcCtD
Oxcarbazepine—Dermatitis—Prednisolone—hematologic cancer	1.66e-05	5.78e-05	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.65e-05	5.77e-05	CcSEcCtD
Oxcarbazepine—Malaise—Epirubicin—hematologic cancer	1.65e-05	5.76e-05	CcSEcCtD
Oxcarbazepine—Fatigue—Prednisone—hematologic cancer	1.65e-05	5.74e-05	CcSEcCtD
Oxcarbazepine—Headache—Prednisolone—hematologic cancer	1.65e-05	5.74e-05	CcSEcCtD
Oxcarbazepine—Discomfort—Methotrexate—hematologic cancer	1.65e-05	5.74e-05	CcSEcCtD
Oxcarbazepine—Nervousness—Doxorubicin—hematologic cancer	1.65e-05	5.74e-05	CcSEcCtD
Oxcarbazepine—Vertigo—Epirubicin—hematologic cancer	1.65e-05	5.74e-05	CcSEcCtD
Oxcarbazepine—Syncope—Epirubicin—hematologic cancer	1.64e-05	5.73e-05	CcSEcCtD
Oxcarbazepine—Leukopenia—Epirubicin—hematologic cancer	1.64e-05	5.71e-05	CcSEcCtD
Oxcarbazepine—Back pain—Doxorubicin—hematologic cancer	1.64e-05	5.71e-05	CcSEcCtD
Oxcarbazepine—Constipation—Prednisone—hematologic cancer	1.63e-05	5.7e-05	CcSEcCtD
Oxcarbazepine—Palpitations—Epirubicin—hematologic cancer	1.62e-05	5.64e-05	CcSEcCtD
Oxcarbazepine—Confusional state—Methotrexate—hematologic cancer	1.61e-05	5.61e-05	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Epirubicin—hematologic cancer	1.61e-05	5.61e-05	CcSEcCtD
Oxcarbazepine—Dizziness—Triamcinolone—hematologic cancer	1.6e-05	5.58e-05	CcSEcCtD
Oxcarbazepine—Cough—Epirubicin—hematologic cancer	1.6e-05	5.57e-05	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Methotrexate—hematologic cancer	1.6e-05	5.57e-05	CcSEcCtD
Oxcarbazepine—Vision blurred—Doxorubicin—hematologic cancer	1.6e-05	5.57e-05	CcSEcCtD
Oxcarbazepine—Convulsion—Epirubicin—hematologic cancer	1.59e-05	5.53e-05	CcSEcCtD
Oxcarbazepine—Infection—Methotrexate—hematologic cancer	1.59e-05	5.53e-05	CcSEcCtD
Oxcarbazepine—Nausea—Etoposide—hematologic cancer	1.58e-05	5.52e-05	CcSEcCtD
Oxcarbazepine—Hypertension—Epirubicin—hematologic cancer	1.58e-05	5.51e-05	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Prednisone—hematologic cancer	1.58e-05	5.49e-05	CcSEcCtD
Oxcarbazepine—Asthenia—Dexamethasone—hematologic cancer	1.57e-05	5.49e-05	CcSEcCtD
Oxcarbazepine—Asthenia—Betamethasone—hematologic cancer	1.57e-05	5.49e-05	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Doxorubicin—hematologic cancer	1.57e-05	5.48e-05	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Methotrexate—hematologic cancer	1.57e-05	5.46e-05	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Methotrexate—hematologic cancer	1.56e-05	5.45e-05	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Prednisone—hematologic cancer	1.56e-05	5.45e-05	CcSEcCtD
Oxcarbazepine—Nausea—Prednisolone—hematologic cancer	1.56e-05	5.45e-05	CcSEcCtD
Oxcarbazepine—Myalgia—Epirubicin—hematologic cancer	1.56e-05	5.44e-05	CcSEcCtD
Oxcarbazepine—Chest pain—Epirubicin—hematologic cancer	1.56e-05	5.44e-05	CcSEcCtD
Oxcarbazepine—Arthralgia—Epirubicin—hematologic cancer	1.56e-05	5.44e-05	CcSEcCtD
Oxcarbazepine—Agitation—Doxorubicin—hematologic cancer	1.56e-05	5.43e-05	CcSEcCtD
Oxcarbazepine—Anxiety—Epirubicin—hematologic cancer	1.55e-05	5.42e-05	CcSEcCtD
Oxcarbazepine—Pruritus—Dexamethasone—hematologic cancer	1.55e-05	5.41e-05	CcSEcCtD
Oxcarbazepine—Pruritus—Betamethasone—hematologic cancer	1.55e-05	5.41e-05	CcSEcCtD
Oxcarbazepine—Skin disorder—Methotrexate—hematologic cancer	1.55e-05	5.41e-05	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.55e-05	5.4e-05	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Methotrexate—hematologic cancer	1.54e-05	5.38e-05	CcSEcCtD
Oxcarbazepine—Discomfort—Epirubicin—hematologic cancer	1.54e-05	5.37e-05	CcSEcCtD
Oxcarbazepine—Vomiting—Triamcinolone—hematologic cancer	1.54e-05	5.36e-05	CcSEcCtD
Oxcarbazepine—Malaise—Doxorubicin—hematologic cancer	1.53e-05	5.33e-05	CcSEcCtD
Oxcarbazepine—Rash—Triamcinolone—hematologic cancer	1.53e-05	5.32e-05	CcSEcCtD
Oxcarbazepine—Dry mouth—Epirubicin—hematologic cancer	1.53e-05	5.32e-05	CcSEcCtD
Oxcarbazepine—Dermatitis—Triamcinolone—hematologic cancer	1.52e-05	5.31e-05	CcSEcCtD
Oxcarbazepine—Vertigo—Doxorubicin—hematologic cancer	1.52e-05	5.31e-05	CcSEcCtD
Oxcarbazepine—Anorexia—Methotrexate—hematologic cancer	1.52e-05	5.31e-05	CcSEcCtD
Oxcarbazepine—Syncope—Doxorubicin—hematologic cancer	1.52e-05	5.3e-05	CcSEcCtD
Oxcarbazepine—Urticaria—Prednisone—hematologic cancer	1.52e-05	5.29e-05	CcSEcCtD
Oxcarbazepine—Leukopenia—Doxorubicin—hematologic cancer	1.52e-05	5.29e-05	CcSEcCtD
Oxcarbazepine—Headache—Triamcinolone—hematologic cancer	1.52e-05	5.28e-05	CcSEcCtD
Oxcarbazepine—Abdominal pain—Prednisone—hematologic cancer	1.51e-05	5.27e-05	CcSEcCtD
Oxcarbazepine—Body temperature increased—Prednisone—hematologic cancer	1.51e-05	5.27e-05	CcSEcCtD
Oxcarbazepine—Confusional state—Epirubicin—hematologic cancer	1.51e-05	5.25e-05	CcSEcCtD
Oxcarbazepine—Diarrhoea—Betamethasone—hematologic cancer	1.5e-05	5.23e-05	CcSEcCtD
Oxcarbazepine—Diarrhoea—Dexamethasone—hematologic cancer	1.5e-05	5.23e-05	CcSEcCtD
Oxcarbazepine—Palpitations—Doxorubicin—hematologic cancer	1.5e-05	5.22e-05	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Epirubicin—hematologic cancer	1.5e-05	5.21e-05	CcSEcCtD
Oxcarbazepine—Hypotension—Methotrexate—hematologic cancer	1.49e-05	5.2e-05	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Doxorubicin—hematologic cancer	1.49e-05	5.19e-05	CcSEcCtD
Oxcarbazepine—Infection—Epirubicin—hematologic cancer	1.49e-05	5.18e-05	CcSEcCtD
Oxcarbazepine—Cough—Doxorubicin—hematologic cancer	1.48e-05	5.15e-05	CcSEcCtD
Oxcarbazepine—Shock—Epirubicin—hematologic cancer	1.47e-05	5.13e-05	CcSEcCtD
Oxcarbazepine—Convulsion—Doxorubicin—hematologic cancer	1.47e-05	5.12e-05	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Epirubicin—hematologic cancer	1.47e-05	5.11e-05	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Epirubicin—hematologic cancer	1.46e-05	5.1e-05	CcSEcCtD
Oxcarbazepine—Hypertension—Doxorubicin—hematologic cancer	1.46e-05	5.1e-05	CcSEcCtD
Oxcarbazepine—Tachycardia—Epirubicin—hematologic cancer	1.46e-05	5.09e-05	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.46e-05	5.07e-05	CcSEcCtD
Oxcarbazepine—Skin disorder—Epirubicin—hematologic cancer	1.45e-05	5.06e-05	CcSEcCtD
Oxcarbazepine—Dizziness—Dexamethasone—hematologic cancer	1.45e-05	5.06e-05	CcSEcCtD
Oxcarbazepine—Dizziness—Betamethasone—hematologic cancer	1.45e-05	5.06e-05	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Epirubicin—hematologic cancer	1.45e-05	5.04e-05	CcSEcCtD
Oxcarbazepine—Insomnia—Methotrexate—hematologic cancer	1.44e-05	5.04e-05	CcSEcCtD
Oxcarbazepine—Arthralgia—Doxorubicin—hematologic cancer	1.44e-05	5.03e-05	CcSEcCtD
Oxcarbazepine—Myalgia—Doxorubicin—hematologic cancer	1.44e-05	5.03e-05	CcSEcCtD
Oxcarbazepine—Chest pain—Doxorubicin—hematologic cancer	1.44e-05	5.03e-05	CcSEcCtD
Oxcarbazepine—Anxiety—Doxorubicin—hematologic cancer	1.44e-05	5.01e-05	CcSEcCtD
Oxcarbazepine—Nausea—Triamcinolone—hematologic cancer	1.44e-05	5.01e-05	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.43e-05	4.99e-05	CcSEcCtD
Oxcarbazepine—Discomfort—Doxorubicin—hematologic cancer	1.43e-05	4.97e-05	CcSEcCtD
Oxcarbazepine—Anorexia—Epirubicin—hematologic cancer	1.43e-05	4.97e-05	CcSEcCtD
Oxcarbazepine—Dyspnoea—Methotrexate—hematologic cancer	1.42e-05	4.96e-05	CcSEcCtD
Oxcarbazepine—Somnolence—Methotrexate—hematologic cancer	1.42e-05	4.95e-05	CcSEcCtD
Oxcarbazepine—Dry mouth—Doxorubicin—hematologic cancer	1.41e-05	4.92e-05	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Prednisone—hematologic cancer	1.41e-05	4.91e-05	CcSEcCtD
Oxcarbazepine—Dyspepsia—Methotrexate—hematologic cancer	1.41e-05	4.9e-05	CcSEcCtD
Oxcarbazepine—Hypotension—Epirubicin—hematologic cancer	1.4e-05	4.87e-05	CcSEcCtD
Oxcarbazepine—Vomiting—Betamethasone—hematologic cancer	1.4e-05	4.86e-05	CcSEcCtD
Oxcarbazepine—Vomiting—Dexamethasone—hematologic cancer	1.4e-05	4.86e-05	CcSEcCtD
Oxcarbazepine—Confusional state—Doxorubicin—hematologic cancer	1.39e-05	4.86e-05	CcSEcCtD
Oxcarbazepine—Decreased appetite—Methotrexate—hematologic cancer	1.39e-05	4.84e-05	CcSEcCtD
Oxcarbazepine—Rash—Betamethasone—hematologic cancer	1.38e-05	4.82e-05	CcSEcCtD
Oxcarbazepine—Rash—Dexamethasone—hematologic cancer	1.38e-05	4.82e-05	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Doxorubicin—hematologic cancer	1.38e-05	4.82e-05	CcSEcCtD
Oxcarbazepine—Dermatitis—Betamethasone—hematologic cancer	1.38e-05	4.82e-05	CcSEcCtD
Oxcarbazepine—Dermatitis—Dexamethasone—hematologic cancer	1.38e-05	4.82e-05	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.38e-05	4.81e-05	CcSEcCtD
Oxcarbazepine—Fatigue—Methotrexate—hematologic cancer	1.38e-05	4.8e-05	CcSEcCtD
Oxcarbazepine—Headache—Dexamethasone—hematologic cancer	1.38e-05	4.79e-05	CcSEcCtD
Oxcarbazepine—Headache—Betamethasone—hematologic cancer	1.38e-05	4.79e-05	CcSEcCtD
Oxcarbazepine—Infection—Doxorubicin—hematologic cancer	1.37e-05	4.79e-05	CcSEcCtD
Oxcarbazepine—Asthenia—Prednisone—hematologic cancer	1.37e-05	4.78e-05	CcSEcCtD
Oxcarbazepine—Pain—Methotrexate—hematologic cancer	1.37e-05	4.76e-05	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.36e-05	4.75e-05	CcSEcCtD
Oxcarbazepine—Shock—Doxorubicin—hematologic cancer	1.36e-05	4.74e-05	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Doxorubicin—hematologic cancer	1.36e-05	4.73e-05	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Doxorubicin—hematologic cancer	1.35e-05	4.72e-05	CcSEcCtD
Oxcarbazepine—Pruritus—Prednisone—hematologic cancer	1.35e-05	4.71e-05	CcSEcCtD
Oxcarbazepine—Insomnia—Epirubicin—hematologic cancer	1.35e-05	4.71e-05	CcSEcCtD
Oxcarbazepine—Tachycardia—Doxorubicin—hematologic cancer	1.35e-05	4.71e-05	CcSEcCtD
Oxcarbazepine—Skin disorder—Doxorubicin—hematologic cancer	1.34e-05	4.68e-05	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Doxorubicin—hematologic cancer	1.34e-05	4.66e-05	CcSEcCtD
Oxcarbazepine—Dyspnoea—Epirubicin—hematologic cancer	1.33e-05	4.65e-05	CcSEcCtD
Oxcarbazepine—Somnolence—Epirubicin—hematologic cancer	1.33e-05	4.63e-05	CcSEcCtD
Oxcarbazepine—Anorexia—Doxorubicin—hematologic cancer	1.32e-05	4.6e-05	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Methotrexate—hematologic cancer	1.32e-05	4.59e-05	CcSEcCtD
Oxcarbazepine—Dyspepsia—Epirubicin—hematologic cancer	1.32e-05	4.59e-05	CcSEcCtD
Oxcarbazepine—Diarrhoea—Prednisone—hematologic cancer	1.31e-05	4.56e-05	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Methotrexate—hematologic cancer	1.31e-05	4.55e-05	CcSEcCtD
Oxcarbazepine—Nausea—Betamethasone—hematologic cancer	1.3e-05	4.54e-05	CcSEcCtD
Oxcarbazepine—Nausea—Dexamethasone—hematologic cancer	1.3e-05	4.54e-05	CcSEcCtD
Oxcarbazepine—Decreased appetite—Epirubicin—hematologic cancer	1.3e-05	4.53e-05	CcSEcCtD
Oxcarbazepine—Hypotension—Doxorubicin—hematologic cancer	1.29e-05	4.5e-05	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.29e-05	4.5e-05	CcSEcCtD
Oxcarbazepine—Fatigue—Epirubicin—hematologic cancer	1.29e-05	4.49e-05	CcSEcCtD
Oxcarbazepine—Pain—Epirubicin—hematologic cancer	1.28e-05	4.46e-05	CcSEcCtD
Oxcarbazepine—Constipation—Epirubicin—hematologic cancer	1.28e-05	4.46e-05	CcSEcCtD
Oxcarbazepine—CYP3A4—Metabolism—PHYH—hematologic cancer	1.27e-05	0.000349	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—FTCD—hematologic cancer	1.27e-05	0.000349	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—ABL1—hematologic cancer	1.27e-05	0.000348	CbGpPWpGaD
Oxcarbazepine—Urticaria—Methotrexate—hematologic cancer	1.27e-05	4.42e-05	CcSEcCtD
Oxcarbazepine—Dizziness—Prednisone—hematologic cancer	1.26e-05	4.41e-05	CcSEcCtD
Oxcarbazepine—Abdominal pain—Methotrexate—hematologic cancer	1.26e-05	4.4e-05	CcSEcCtD
Oxcarbazepine—Body temperature increased—Methotrexate—hematologic cancer	1.26e-05	4.4e-05	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.26e-05	4.39e-05	CcSEcCtD
Oxcarbazepine—CYP3A5—Metabolism—ARNTL—hematologic cancer	1.26e-05	0.000345	CbGpPWpGaD
Oxcarbazepine—Insomnia—Doxorubicin—hematologic cancer	1.25e-05	4.36e-05	CcSEcCtD
Oxcarbazepine—CYP2C19—Metabolism—MTAP—hematologic cancer	1.25e-05	0.000342	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—FHL2—hematologic cancer	1.24e-05	0.00034	CbGpPWpGaD
Oxcarbazepine—Dyspnoea—Doxorubicin—hematologic cancer	1.23e-05	4.3e-05	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Epirubicin—hematologic cancer	1.23e-05	4.29e-05	CcSEcCtD
Oxcarbazepine—Somnolence—Doxorubicin—hematologic cancer	1.23e-05	4.29e-05	CcSEcCtD
Oxcarbazepine—SCN5A—Developmental Biology—TNF—hematologic cancer	1.23e-05	0.000337	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CA9—hematologic cancer	1.22e-05	0.000335	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ACP5—hematologic cancer	1.22e-05	0.000335	CbGpPWpGaD
Oxcarbazepine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.22e-05	4.26e-05	CcSEcCtD
Oxcarbazepine—SCN5A—Developmental Biology—KRAS—hematologic cancer	1.22e-05	0.000334	CbGpPWpGaD
Oxcarbazepine—Dyspepsia—Doxorubicin—hematologic cancer	1.22e-05	4.24e-05	CcSEcCtD
Oxcarbazepine—ALB—Metabolism—AGRN—hematologic cancer	1.22e-05	0.000333	CbGpPWpGaD
Oxcarbazepine—Vomiting—Prednisone—hematologic cancer	1.22e-05	4.24e-05	CcSEcCtD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	1.21e-05	0.000332	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NCOR2—hematologic cancer	1.21e-05	0.000331	CbGpPWpGaD
Oxcarbazepine—Rash—Prednisone—hematologic cancer	1.21e-05	4.2e-05	CcSEcCtD
Oxcarbazepine—Dermatitis—Prednisone—hematologic cancer	1.2e-05	4.2e-05	CcSEcCtD
Oxcarbazepine—Decreased appetite—Doxorubicin—hematologic cancer	1.2e-05	4.19e-05	CcSEcCtD
Oxcarbazepine—Headache—Prednisone—hematologic cancer	1.2e-05	4.17e-05	CcSEcCtD
Oxcarbazepine—ALB—Hemostasis—HGF—hematologic cancer	1.19e-05	0.000327	CbGpPWpGaD
Oxcarbazepine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.19e-05	4.16e-05	CcSEcCtD
Oxcarbazepine—Fatigue—Doxorubicin—hematologic cancer	1.19e-05	4.16e-05	CcSEcCtD
Oxcarbazepine—Urticaria—Epirubicin—hematologic cancer	1.19e-05	4.14e-05	CcSEcCtD
Oxcarbazepine—Pain—Doxorubicin—hematologic cancer	1.18e-05	4.12e-05	CcSEcCtD
Oxcarbazepine—Constipation—Doxorubicin—hematologic cancer	1.18e-05	4.12e-05	CcSEcCtD
Oxcarbazepine—Body temperature increased—Epirubicin—hematologic cancer	1.18e-05	4.12e-05	CcSEcCtD
Oxcarbazepine—Abdominal pain—Epirubicin—hematologic cancer	1.18e-05	4.12e-05	CcSEcCtD
Oxcarbazepine—ALB—Hemostasis—CSF2—hematologic cancer	1.18e-05	0.000323	CbGpPWpGaD
Oxcarbazepine—Hypersensitivity—Methotrexate—hematologic cancer	1.18e-05	4.1e-05	CcSEcCtD
Oxcarbazepine—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.17e-05	0.000319	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—IDH2—hematologic cancer	1.15e-05	0.000316	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—HMMR—hematologic cancer	1.15e-05	0.000316	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—IDH1—hematologic cancer	1.15e-05	0.000315	CbGpPWpGaD
Oxcarbazepine—Asthenia—Methotrexate—hematologic cancer	1.15e-05	3.99e-05	CcSEcCtD
Oxcarbazepine—ALB—Hemostasis—JAK1—hematologic cancer	1.14e-05	0.000312	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PRKCG—hematologic cancer	1.14e-05	0.000312	CbGpPWpGaD
Oxcarbazepine—Feeling abnormal—Doxorubicin—hematologic cancer	1.14e-05	3.97e-05	CcSEcCtD
Oxcarbazepine—CYP3A5—Metabolism—ABCC3—hematologic cancer	1.14e-05	0.000312	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—TXN—hematologic cancer	1.14e-05	0.000312	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTO1—hematologic cancer	1.14e-05	0.000312	CbGpPWpGaD
Oxcarbazepine—Nausea—Prednisone—hematologic cancer	1.14e-05	3.96e-05	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.13e-05	3.94e-05	CcSEcCtD
Oxcarbazepine—Pruritus—Methotrexate—hematologic cancer	1.13e-05	3.94e-05	CcSEcCtD
Oxcarbazepine—CYP3A5—Metabolism—SPHK1—hematologic cancer	1.11e-05	0.000305	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—FHL2—hematologic cancer	1.11e-05	0.000305	CbGpPWpGaD
Oxcarbazepine—Hypersensitivity—Epirubicin—hematologic cancer	1.1e-05	3.84e-05	CcSEcCtD
Oxcarbazepine—Urticaria—Doxorubicin—hematologic cancer	1.1e-05	3.83e-05	CcSEcCtD
Oxcarbazepine—Body temperature increased—Doxorubicin—hematologic cancer	1.09e-05	3.81e-05	CcSEcCtD
Oxcarbazepine—Abdominal pain—Doxorubicin—hematologic cancer	1.09e-05	3.81e-05	CcSEcCtD
Oxcarbazepine—Diarrhoea—Methotrexate—hematologic cancer	1.09e-05	3.81e-05	CcSEcCtD
Oxcarbazepine—CYP2C19—Metabolism—AGRN—hematologic cancer	1.09e-05	0.000299	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.09e-05	0.000298	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ARNTL—hematologic cancer	1.08e-05	0.000297	CbGpPWpGaD
Oxcarbazepine—Asthenia—Epirubicin—hematologic cancer	1.07e-05	3.74e-05	CcSEcCtD
Oxcarbazepine—CYP3A5—Metabolism—UGT1A1—hematologic cancer	1.07e-05	0.000293	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.07e-05	0.000292	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IL2RA—hematologic cancer	1.06e-05	0.000292	CbGpPWpGaD
Oxcarbazepine—Pruritus—Epirubicin—hematologic cancer	1.06e-05	3.69e-05	CcSEcCtD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	1.06e-05	0.000289	CbGpPWpGaD
Oxcarbazepine—Dizziness—Methotrexate—hematologic cancer	1.06e-05	3.68e-05	CcSEcCtD
Oxcarbazepine—ALB—Metabolism—ACP5—hematologic cancer	1.05e-05	0.000289	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CA9—hematologic cancer	1.05e-05	0.000289	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SLC22A1—hematologic cancer	1.04e-05	0.000285	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CRABP1—hematologic cancer	1.04e-05	0.000285	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NCOR2—hematologic cancer	1.04e-05	0.000285	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—HRAS—hematologic cancer	1.04e-05	0.000284	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—IDH2—hematologic cancer	1.04e-05	0.000284	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—HMMR—hematologic cancer	1.04e-05	0.000284	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	1.03e-05	0.000282	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PDGFB—hematologic cancer	1.03e-05	0.000281	CbGpPWpGaD
Oxcarbazepine—Diarrhoea—Epirubicin—hematologic cancer	1.02e-05	3.57e-05	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Doxorubicin—hematologic cancer	1.02e-05	3.55e-05	CcSEcCtD
Oxcarbazepine—CYP3A4—Metabolism—DCK—hematologic cancer	1.02e-05	0.000279	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.02e-05	0.000279	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ASNS—hematologic cancer	1.02e-05	0.000279	CbGpPWpGaD
Oxcarbazepine—Vomiting—Methotrexate—hematologic cancer	1.02e-05	3.54e-05	CcSEcCtD
Oxcarbazepine—CYP3A5—Metabolism—ALOX5—hematologic cancer	1.01e-05	0.000278	CbGpPWpGaD
Oxcarbazepine—Rash—Methotrexate—hematologic cancer	1.01e-05	3.51e-05	CcSEcCtD
Oxcarbazepine—Dermatitis—Methotrexate—hematologic cancer	1.01e-05	3.51e-05	CcSEcCtD
Oxcarbazepine—Headache—Methotrexate—hematologic cancer	1e-05	3.49e-05	CcSEcCtD
Oxcarbazepine—ALB—Hemostasis—CDK2—hematologic cancer	9.97e-06	0.000273	CbGpPWpGaD
Oxcarbazepine—Asthenia—Doxorubicin—hematologic cancer	9.92e-06	3.46e-05	CcSEcCtD
Oxcarbazepine—ALB—Metabolism—IDH1—hematologic cancer	9.92e-06	0.000272	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—IL6—hematologic cancer	9.91e-06	0.000272	CbGpPWpGaD
Oxcarbazepine—Dizziness—Epirubicin—hematologic cancer	9.89e-06	3.45e-05	CcSEcCtD
Oxcarbazepine—CYP3A5—Metabolism—NUP98—hematologic cancer	9.83e-06	0.000269	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTO1—hematologic cancer	9.81e-06	0.000269	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—TXN—hematologic cancer	9.81e-06	0.000269	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ABCC3—hematologic cancer	9.81e-06	0.000269	CbGpPWpGaD
Oxcarbazepine—Pruritus—Doxorubicin—hematologic cancer	9.79e-06	3.41e-05	CcSEcCtD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.76e-06	0.000267	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	9.73e-06	0.000267	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ARNTL—hematologic cancer	9.73e-06	0.000267	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HDC—hematologic cancer	9.66e-06	0.000265	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SPHK1—hematologic cancer	9.6e-06	0.000263	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—MAPK14—hematologic cancer	9.56e-06	0.000262	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ADCY7—hematologic cancer	9.54e-06	0.000261	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NCOA3—hematologic cancer	9.54e-06	0.000261	CbGpPWpGaD
Oxcarbazepine—Vomiting—Epirubicin—hematologic cancer	9.51e-06	3.31e-05	CcSEcCtD
Oxcarbazepine—Nausea—Methotrexate—hematologic cancer	9.49e-06	3.31e-05	CcSEcCtD
Oxcarbazepine—CYP3A5—Metabolism—NUP214—hematologic cancer	9.47e-06	0.000259	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ACP5—hematologic cancer	9.47e-06	0.000259	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CA9—hematologic cancer	9.47e-06	0.000259	CbGpPWpGaD
Oxcarbazepine—Diarrhoea—Doxorubicin—hematologic cancer	9.46e-06	3.3e-05	CcSEcCtD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	9.44e-06	0.000259	CbGpPWpGaD
Oxcarbazepine—Rash—Epirubicin—hematologic cancer	9.43e-06	3.29e-05	CcSEcCtD
Oxcarbazepine—Dermatitis—Epirubicin—hematologic cancer	9.42e-06	3.28e-05	CcSEcCtD
Oxcarbazepine—Headache—Epirubicin—hematologic cancer	9.37e-06	3.26e-05	CcSEcCtD
Oxcarbazepine—CYP2C19—Metabolism—NCOR2—hematologic cancer	9.34e-06	0.000256	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ABCG2—hematologic cancer	9.28e-06	0.000254	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—MTR—hematologic cancer	9.28e-06	0.000254	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—FN1—hematologic cancer	9.27e-06	0.000254	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—UGT1A1—hematologic cancer	9.22e-06	0.000252	CbGpPWpGaD
Oxcarbazepine—Dizziness—Doxorubicin—hematologic cancer	9.15e-06	3.19e-05	CcSEcCtD
Oxcarbazepine—SCN5A—Developmental Biology—AKT1—hematologic cancer	9.15e-06	0.000251	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ENO2—hematologic cancer	9.1e-06	0.000249	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SLC22A1—hematologic cancer	8.97e-06	0.000246	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CRABP1—hematologic cancer	8.97e-06	0.000246	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—IDH1—hematologic cancer	8.9e-06	0.000244	CbGpPWpGaD
Oxcarbazepine—Nausea—Epirubicin—hematologic cancer	8.88e-06	3.09e-05	CcSEcCtD
Oxcarbazepine—ALB—Hemostasis—PIK3CG—hematologic cancer	8.87e-06	0.000243	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CDA—hematologic cancer	8.84e-06	0.000242	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTT1—hematologic cancer	8.83e-06	0.000242	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ABCC3—hematologic cancer	8.8e-06	0.000241	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—TXN—hematologic cancer	8.8e-06	0.000241	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTO1—hematologic cancer	8.8e-06	0.000241	CbGpPWpGaD
Oxcarbazepine—Vomiting—Doxorubicin—hematologic cancer	8.8e-06	3.07e-05	CcSEcCtD
Oxcarbazepine—ALB—Metabolism—ALOX5—hematologic cancer	8.74e-06	0.000239	CbGpPWpGaD
Oxcarbazepine—Rash—Doxorubicin—hematologic cancer	8.72e-06	3.04e-05	CcSEcCtD
Oxcarbazepine—Dermatitis—Doxorubicin—hematologic cancer	8.71e-06	3.04e-05	CcSEcCtD
Oxcarbazepine—ALB—Hemostasis—PTPN11—hematologic cancer	8.71e-06	0.000239	CbGpPWpGaD
Oxcarbazepine—Headache—Doxorubicin—hematologic cancer	8.67e-06	3.02e-05	CcSEcCtD
Oxcarbazepine—CYP3A5—Metabolism—SDC1—hematologic cancer	8.63e-06	0.000236	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SPHK1—hematologic cancer	8.61e-06	0.000236	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PC—hematologic cancer	8.5e-06	0.000233	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NUP98—hematologic cancer	8.46e-06	0.000232	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—UGT1A1—hematologic cancer	8.28e-06	0.000227	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—CREBBP—hematologic cancer	8.22e-06	0.000225	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ADCY7—hematologic cancer	8.22e-06	0.000225	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NCOA3—hematologic cancer	8.22e-06	0.000225	CbGpPWpGaD
Oxcarbazepine—Nausea—Doxorubicin—hematologic cancer	8.22e-06	2.86e-05	CcSEcCtD
Oxcarbazepine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	8.21e-06	0.000225	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GBA—hematologic cancer	8.21e-06	0.000225	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NUP214—hematologic cancer	8.16e-06	0.000223	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.07e-06	0.000221	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CRABP1—hematologic cancer	8.05e-06	0.00022	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SLC22A1—hematologic cancer	8.05e-06	0.00022	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	8.04e-06	0.00022	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—MTR—hematologic cancer	7.99e-06	0.000219	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ABCG2—hematologic cancer	7.99e-06	0.000219	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ALOX5—hematologic cancer	7.85e-06	0.000215	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ENO2—hematologic cancer	7.84e-06	0.000215	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CD—hematologic cancer	7.8e-06	0.000214	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTT1—hematologic cancer	7.6e-06	0.000208	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NUP98—hematologic cancer	7.6e-06	0.000208	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MTAP—hematologic cancer	7.51e-06	0.000206	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.49e-06	0.000205	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SDC1—hematologic cancer	7.43e-06	0.000204	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ADCY7—hematologic cancer	7.38e-06	0.000202	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NCOA3—hematologic cancer	7.38e-06	0.000202	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3R1—hematologic cancer	7.36e-06	0.000202	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CD44—hematologic cancer	7.34e-06	0.000201	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NQO1—hematologic cancer	7.34e-06	0.000201	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NUP214—hematologic cancer	7.32e-06	0.000201	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.25e-06	0.000199	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—MTR—hematologic cancer	7.18e-06	0.000197	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ABCG2—hematologic cancer	7.18e-06	0.000197	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—JAK2—hematologic cancer	7.16e-06	0.000196	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.12e-06	0.000195	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.1e-06	0.000194	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ENO2—hematologic cancer	7.04e-06	0.000193	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYCS—hematologic cancer	6.94e-06	0.00019	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	6.9e-06	0.000189	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTT1—hematologic cancer	6.82e-06	0.000187	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CB—hematologic cancer	6.8e-06	0.000186	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.72e-06	0.000184	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.7e-06	0.000184	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—FHL2—hematologic cancer	6.7e-06	0.000183	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SDC1—hematologic cancer	6.67e-06	0.000183	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—AGRN—hematologic cancer	6.57e-06	0.00018	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	6.57e-06	0.00018	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.37e-06	0.000175	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CD44—hematologic cancer	6.32e-06	0.000173	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NQO1—hematologic cancer	6.32e-06	0.000173	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.29e-06	0.000172	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IL2—hematologic cancer	6.24e-06	0.000171	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HMMR—hematologic cancer	6.22e-06	0.00017	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—IDH2—hematologic cancer	6.22e-06	0.00017	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.19e-06	0.000169	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTP1—hematologic cancer	6.12e-06	0.000168	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.02e-06	0.000165	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYCS—hematologic cancer	5.98e-06	0.000164	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—HSP90AA1—hematologic cancer	5.94e-06	0.000163	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.85e-06	0.00016	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ABCB1—hematologic cancer	5.79e-06	0.000159	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ACP5—hematologic cancer	5.69e-06	0.000156	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CA9—hematologic cancer	5.69e-06	0.000156	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NQO1—hematologic cancer	5.67e-06	0.000155	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CD44—hematologic cancer	5.67e-06	0.000155	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NCOR1—hematologic cancer	5.62e-06	0.000154	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTM1—hematologic cancer	5.62e-06	0.000154	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.62e-06	0.000154	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—EP300—hematologic cancer	5.6e-06	0.000153	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.55e-06	0.000152	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—SRC—hematologic cancer	5.45e-06	0.000149	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYCS—hematologic cancer	5.37e-06	0.000147	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—IDH1—hematologic cancer	5.35e-06	0.000147	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.35e-06	0.000146	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	5.33e-06	0.000146	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—VEGFA—hematologic cancer	5.3e-06	0.000145	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.29e-06	0.000145	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.29e-06	0.000145	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TXN—hematologic cancer	5.29e-06	0.000145	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTP1—hematologic cancer	5.27e-06	0.000144	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—NRAS—hematologic cancer	5.24e-06	0.000143	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.18e-06	0.000142	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.1e-06	0.00014	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—MAPK3—hematologic cancer	5.02e-06	0.000137	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ABCB1—hematologic cancer	4.99e-06	0.000137	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.98e-06	0.000136	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—MTHFR—hematologic cancer	4.97e-06	0.000136	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TGFB1—hematologic cancer	4.87e-06	0.000133	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NCOR1—hematologic cancer	4.84e-06	0.000133	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTM1—hematologic cancer	4.84e-06	0.000133	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.84e-06	0.000133	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.84e-06	0.000133	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.8e-06	0.000131	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTP1—hematologic cancer	4.73e-06	0.00013	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.72e-06	0.000129	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.58e-06	0.000125	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NUP98—hematologic cancer	4.57e-06	0.000125	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—KRAS—hematologic cancer	4.51e-06	0.000124	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ABCB1—hematologic cancer	4.48e-06	0.000123	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.44e-06	0.000121	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.44e-06	0.000121	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NUP214—hematologic cancer	4.4e-06	0.000121	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTM1—hematologic cancer	4.35e-06	0.000119	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NCOR1—hematologic cancer	4.35e-06	0.000119	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MTR—hematologic cancer	4.31e-06	0.000118	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.31e-06	0.000118	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—MTHFR—hematologic cancer	4.28e-06	0.000117	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ENO2—hematologic cancer	4.23e-06	0.000116	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	4.18e-06	0.000114	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CA—hematologic cancer	4.14e-06	0.000113	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.1e-06	0.000112	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SDC1—hematologic cancer	4.01e-06	0.00011	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TP53—hematologic cancer	4.01e-06	0.00011	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CREBBP—hematologic cancer	3.87e-06	0.000106	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.84e-06	0.000105	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—HRAS—hematologic cancer	3.83e-06	0.000105	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.77e-06	0.000103	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	3.67e-06	0.000101	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ALB—hematologic cancer	3.62e-06	9.92e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CG—hematologic cancer	3.6e-06	9.85e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	3.47e-06	9.49e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CD44—hematologic cancer	3.41e-06	9.34e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NQO1—hematologic cancer	3.41e-06	9.34e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.39e-06	9.27e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—AKT1—hematologic cancer	3.38e-06	9.27e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CREBBP—hematologic cancer	3.33e-06	9.13e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.23e-06	8.84e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYCS—hematologic cancer	3.23e-06	8.84e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.21e-06	8.78e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	3.2e-06	8.76e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CD—hematologic cancer	3.16e-06	8.66e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.99e-06	8.2e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3R1—hematologic cancer	2.98e-06	8.18e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.84e-06	7.79e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.84e-06	7.77e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ALB—hematologic cancer	2.8e-06	7.67e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PTEN—hematologic cancer	2.76e-06	7.57e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CB—hematologic cancer	2.76e-06	7.55e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.69e-06	7.38e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.68e-06	7.34e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—EP300—hematologic cancer	2.64e-06	7.22e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.61e-06	7.16e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.61e-06	7.16e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.47e-06	6.77e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PTEN—hematologic cancer	2.38e-06	6.52e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.31e-06	6.33e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—EP300—hematologic cancer	2.27e-06	6.22e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PTEN—hematologic cancer	2.14e-06	5.85e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—EP300—hematologic cancer	2.04e-06	5.58e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.95e-06	5.34e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.94e-06	5.32e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.8e-06	4.93e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.71e-06	4.67e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ALB—hematologic cancer	1.68e-06	4.61e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CA—hematologic cancer	1.68e-06	4.6e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.61e-06	4.41e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—AKT1—hematologic cancer	1.59e-06	4.36e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.51e-06	4.13e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.49e-06	4.07e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—AKT1—hematologic cancer	1.37e-06	3.76e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.29e-06	3.52e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—AKT1—hematologic cancer	1.23e-06	3.37e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—EP300—hematologic cancer	1.23e-06	3.36e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.07e-07	2.48e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—AKT1—hematologic cancer	7.41e-07	2.03e-05	CbGpPWpGaD
